Avalo Therapeutics Inc’s recent filing unveils that its Director Almenoff June Sherie acquired Company’s shares for reported $6500.0 on Nov 13 ’24. In the deal valued at $13.00 per share,500 shares were bought. As a result of this transaction, Almenoff June Sherie now holds 1,000 shares worth roughly $8910.0.
Then, Almenoff June Sherie bought 500 shares, generating $6,250 in total proceeds. Upon buying the shares at $12.50, the Director now owns 500 shares.
BTIG Research initiated its Avalo Therapeutics Inc [AVTX] rating to a Buy in a research note published on December 19, 2024; the price target was $40. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late October with a ‘”a Neutral”‘ rating. Oppenheimer also remained covering AVTX and has increased its forecast on April 16, 2024 with a “an Outperform” recommendation from previously “Perform” rating. RBC Capital Mkts started covering the stock on September 24, 2021. It rated AVTX as “an Outperform”.
Price Performance Review of AVTX
On Friday, Avalo Therapeutics Inc [NASDAQ:AVTX] saw its stock fall -1.87% to $8.91. Over the last five days, the stock has lost -3.47%. Avalo Therapeutics Inc shares have fallen nearly -2.09% since the year began. Nevertheless, the stocks have fallen -13.66% over the past one year. While a 52-week high of $34.46 was reached on 03/28/24, a 52-week low of $3.95 was recorded on 01/17/24. SMA at 50 days reached $11.14, while 200 days put it at $11.01.
Levels Of Support And Resistance For AVTX Stock
The 24-hour chart illustrates a support level at 8.45, which if violated will result in even more drops to 7.99. On the upside, there is a resistance level at 9.59. A further resistance level may holdings at 10.27. The Relative Strength Index (RSI) on the 14-day chart is 34.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.49, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.79%. Stochastics %K at 10.86% indicates the stock is a buying.
How much short interest is there in Avalo Therapeutics Inc?
A steep rise in short interest was recorded in Avalo Therapeutics Inc stocks on 2024-11-29, dropping by 4839.0 shares to a total of 5218.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 10057.0 shares. There was a decline of -92.74%, which implies that there is a negative sentiment for the stock.
